German Biotech BioNTech Locks in $270M Series A Post author:Sam Post published:January 3, 2018 Post category:BioPharma The Company previously completed a seed round fundraising in 2008 concurrent with its founding. Source: BioSpace You Might Also Like Allergy Therapeutics: Trading Update July 17, 2017 Struggling The Medicines Company Deals Its Infectious Disease Biz to Melinta for $270M November 28, 2017 Achaogen Announces Leadership Promotions February 23, 2017
Struggling The Medicines Company Deals Its Infectious Disease Biz to Melinta for $270M November 28, 2017